PSCHvsBBPETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.79% for BBP. PSCH is up 8.5% year-to-date (YTD) with -$17M in YTD flows. BBP performs better with 9.25% YTD performance, and +$30M in YTD flows. Run a side-by-side ETF comparison of PSCH and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH BBP | +6.00%-1.38% | +19.98%+7.00% | +8.50%+9.25% | +16.31%+43.65% | +8.09%+60.05% | -24.67%+58.90% |
| Flows | PSCH BBP | +$492K+$4M | -$3M+$26M | -$17M+$30M | -$27M+$42M | -$150M+$45M | -$235M+$38M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH BBP | +21.44%+28.75% | +20.54%+24.06% | +21.72%+24.00% | +22.89%+26.36% |
| Max drawdown | PSCH BBP | -4.51%-7.49% | -15.36%-9.59% | -22.80%-25.54% | -47.23%-37.87% |
| Max drawdown duration | PSCH BBP | 13d37d | 168d48d | 478d292d | 1811d760d |
Trading data
PSCH | BBP | |
Last sale 6/12/2026 at 1:30 PM | $47.79 | $87.17 |
| Previous close 06/11/2026 | $47.74 | $86.80 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PSCH | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
PSCH | BBP | |
|---|---|---|
| Last price | $47.79 | $87.17 |
| 1D performance | +0.10% | +0.42% |
| AuM | $140.15 M | $78.43 M |
| E/R | 0.29% | 0.79% |
Characteristics
PSCH | BBP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | VIRTUS Investment Partners |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | LifeSci Biotechnology Products Index |
| N° of holdings | 71 | 55 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
96.15%
Other
3.85%
BBP
USA
84.13%
Other
15.87%
Sectors
PSCH
Health Care
90.67%
Other
9.33%
BBP
Health Care
85.97%
Other
14.03%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
44.63%
BBP
Total weight of top 15 holdings out of 15
45.32%
Top 15 holdings
Data as of April 30, 2026
PSCH
MOLINA HLTHCRE
4.96%
KRYSTAL BIOTECH INC
3.79%
GLAUKOS
3.77%
US10950A1060
3.46%
TELEFLEX
3.21%
PROTAGONIST THERAPEUTICS INC
3.11%
ALKERMES
3.00%
PTC THERAPEUTI/D
2.99%
TG THERAPEUTICS
2.59%
LIGAND PHARMACEUTICALS
2.56%
CORCEPT THERAPEUTICS
2.33%
US45579U1097
2.30%
APELLIS PHARMACEUTICALS
2.26%
RADNET
2.16%
MERIT MEDICAL SYSTEMS
2.15%
BBP
ARROWHEAD PHARMACEUTICALS INC
3.17%
GB00BRXB0C07
3.17%
BIOGEN INC
3.14%
HALOZYME THERAPEUTICS
3.13%
AURINIA PHARMACEUTICALS INC
3.12%
SYNDAX PHARMACEUTICALS INC
3.12%
BIOMARIN PHARMACEUTICAL
3.05%
INCYTE
3.03%
REGENERON PHARMACEUTICALS
3.03%
BRIDGEBIO PHARMA
3.00%
SAREPTA THERAPEUTICS INC DE
2.95%
ARDELYX
2.92%
VERTEX PHARMACEUTICALS
2.85%
US07725L1026
2.83%
THERAVANCE BIOPHARMA
2.80%
Frequently asked questions about PSCH and BBP
How have the PSCH and BBP ETFs performed in 2026?
As of June 12, 2026, PSCH is up 8.5% year-to-date (YTD), while BBP has returned 9.25%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or BBP?
Year-to-date, the PSCH ETF saw -$17M in flows, compared to +$30M for BBP.
Which ETF is more volatile: PSCH or BBP?
Over the past year, PSCH had a volatility of 20.54%, while BBP experienced 24.06%.
Which ETF is bigger: PSCH or BBP?
As of June 12, 2026, PSCH holds $140.15 M in assets under management (AUM), while BBP manages $78.43 M.
What sectors do the PSCH and BBP ETFs invest in?
PSCH leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.
What are the top holdings of the PSCH ETF and BBP ETF?
PSCH top holdings include MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS. BBP holds in its top three: ARROWHEAD PHARMACEUTICALS INC, GB00BRXB0C07 and BIOGEN INC.
Which ETF is more diversified: PSCH or BBP?
PSCH holds 75 securities with 44.63% of its assets in the top 15. BBP has 59 securities and a top 15 weight of 45.32%.
Advertisement
Advertisement
